These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 12631596)
21. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma. Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731 [TBL] [Abstract][Full Text] [Related]
23. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma]. Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796 [TBL] [Abstract][Full Text] [Related]
24. Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors. Levin VA; Chamberlain MC; Prados MD; Choucair AK; Berger MS; Silver P; Seager M; Gutin PH; Davis RL; Wilson CB Cancer Treat Rep; 1987 May; 71(5):459-64. PubMed ID: 3105881 [TBL] [Abstract][Full Text] [Related]
25. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527 [TBL] [Abstract][Full Text] [Related]
26. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO. Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ; J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940 [TBL] [Abstract][Full Text] [Related]
27. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
28. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136 [TBL] [Abstract][Full Text] [Related]
29. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880 [TBL] [Abstract][Full Text] [Related]
30. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Abrey LE; Childs BH; Paleologos N; Kaminer L; Rosenfeld S; Salzman D; Finlay JL; Gardner S; Peterson K; Hu W; Swinnen L; Bayer R; Forsyth P; Stewart D; Smith AM; Macdonald DR; Weaver S; Ramsay DA; Nimer SD; DeAngelis LM; Cairncross JG Neuro Oncol; 2006 Apr; 8(2):183-8. PubMed ID: 16524945 [TBL] [Abstract][Full Text] [Related]
31. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. ; Cairncross G; Berkey B; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperierre N; Mehta M; Curran W J Clin Oncol; 2006 Jun; 24(18):2707-14. PubMed ID: 16782910 [TBL] [Abstract][Full Text] [Related]
36. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889 [TBL] [Abstract][Full Text] [Related]
37. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. Venturini M; Del Mastro L; Aitini E; Baldini E; Caroti C; Contu A; Testore F; Brema F; Pronzato P; Cavazzini G; Sertoli MR; Canavese G; Rosso R; Bruzzi P J Natl Cancer Inst; 2005 Dec; 97(23):1724-33. PubMed ID: 16333028 [TBL] [Abstract][Full Text] [Related]
38. Radiotherapy in supratentorial gliomas. A study of 821 cases. Heesters M; Molenaar W; Go GK Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126 [TBL] [Abstract][Full Text] [Related]
39. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas. Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736 [TBL] [Abstract][Full Text] [Related]
40. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study. Beauchesne PD; Taillandier L; Bernier V; Carnin C Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]